tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KPTI Stock Latest News

Largest borrow rate increases among liquid names
The FlyLargest borrow rate increases among liquid names
4d ago
FIG
TBT
Karyopharm Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Karyopharm Therapeutics’ Earnings Call: Progress Amid Challenges
5d ago
KPTI
Karyopharm price target lowered to $19 from $30 at RBC Capital
PremiumThe Fly
Karyopharm price target lowered to $19 from $30 at RBC Capital
5d ago
KPTI
Karyopharm Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Karyopharm Therapeutics Reports Q3 2025 Financial Results
5d ago
KPTI
Karyopharm files to sell 9.57M shares of common stock for holders
PremiumThe Fly
Karyopharm files to sell 9.57M shares of common stock for holders
6d ago
KPTI
Karyopharm files to sell 2.81M shares of common stock for holders
PremiumThe FlyKaryopharm files to sell 2.81M shares of common stock for holders
6d ago
KPTI
Karyopharm reports Q3 EPS ($3.82), consensus ($3.25)
Premium
The Fly
Karyopharm reports Q3 EPS ($3.82), consensus ($3.25)
6d ago
KPTI
Karyopharm sees FY25 revenue $140M-$155M, consensus $150.22M
Premium
The Fly
Karyopharm sees FY25 revenue $140M-$155M, consensus $150.22M
6d ago
KPTI
KPTI Earnings this Week: How Will it Perform?
PremiumPre-Earnings
KPTI Earnings this Week: How Will it Perform?
12d ago
KPTI
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
20d ago
FIG
SCO
Karyopharm Therapeutics Completes Financing Transactions for Growth
PremiumCompany Announcements
Karyopharm Therapeutics Completes Financing Transactions for Growth
26d ago
8K
KPTI
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
27d ago
BNC
PLG
Karyopharm upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe FlyKaryopharm upgraded to Buy from Neutral at H.C. Wainwright
27d ago
KPTI
Karyopharm price target lowered to $21 from $25 at Baird
Premium
The Fly
Karyopharm price target lowered to $21 from $25 at Baird
1M ago
KPTI
Karyopharm Therapeutics: Strategic Financing Extends Cash Runway Amid Cautious Hold Rating
Premium
Ratings
Karyopharm Therapeutics: Strategic Financing Extends Cash Runway Amid Cautious Hold Rating
1M ago
KPTI
Karyopharm price target lowered to $6 from $8 at Leerink
PremiumThe Fly
Karyopharm price target lowered to $6 from $8 at Leerink
1M ago
KPTI
Morning Movers: AST SpaceMobile jumps after direct-to-cellular pact with Verizon
PremiumThe Fly
Morning Movers: AST SpaceMobile jumps after direct-to-cellular pact with Verizon
1M ago
FDX
MRX
Karyopharm Secures $100M Financing for Clinical Trials
PremiumCompany Announcements
Karyopharm Secures $100M Financing for Clinical Trials
1M ago
8K
KPTI
Karyopharm announces $100M strategic financing plan
PremiumThe Fly
Karyopharm announces $100M strategic financing plan
1M ago
KPTI
Karyopharm sees Q3 revenue $42-$44M, consensus $39.56M
PremiumThe FlyKaryopharm sees Q3 revenue $42-$44M, consensus $39.56M
1M ago
KPTI
Selinexor Study Withdrawal: Implications for Karyopharm Therapeutics
Premium
Company Announcements
Selinexor Study Withdrawal: Implications for Karyopharm Therapeutics
1M ago
KPTI
Karyopharm Therapeutics Board Member Resigns Amid Career Shift
Premium
Company Announcements
Karyopharm Therapeutics Board Member Resigns Amid Career Shift
2M ago
8K
KPTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >